— Know what they know.
Not Investment Advice
Also trades as: IMU.AX (ASX) · $vol 0M

IUGNF Earnings

Imugene Limited
1W: -28.6% 1M: -50.0% 3M: -58.4% YTD: -90.7% 1Y: -87.2% 3Y: -98.2% 5Y: -99.8%
$0.02
-0.00 (-10.75%)
 
Weekly Expected Move ±41.4%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $12.2M mcap · 278M float · 0.0098% daily turnover · Short 79% of daily vol
Last Earnings 2026-08-28
EPS
A$-0.02 (US$-0.01)
▲ Beat +17.1%
Revenue
A$1M ($890K)
▲ Beat +32.2%
EPS Beat Streak: 4 quarters

Estimate vs Actual

Earnings Surprise History

6/19
EPS Beats
2/19
Revenue Beats
32%
EPS Beat Rate
11%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2028-06-30 A$-0.06 A$-0.06 — A$17,456,453 A$17,456,453
2026-10-02 annual 2029-06-30 A$1.70 A$1.70 — A$970,418,250 A$967,777,447
2026-10-02 annual 2027-06-30 A$-0.06 A$-0.06 — A$1,731,791 A$1,731,791
2026-10-01 annual 2028-06-30 A$-0.06 A$-0.06 — A$17,456,453 A$17,456,453
2026-10-01 annual 2029-06-30 A$1.72 A$1.70 ▼ 0.02 A$980,450,507 A$970,418,250
2026-10-01 annual 2027-06-30 A$-0.06 A$-0.06 — A$1,731,791 A$1,731,791
2026-09-29 annual 2027-06-30 A$-0.06 A$-0.06 — A$1,731,791 A$1,731,791
2026-09-29 annual 2028-06-30 A$-0.06 A$-0.06 — A$17,456,453 A$17,456,453
2026-09-29 annual 2029-06-30 A$1.72 A$1.72 — A$981,288,857 A$980,450,507
2026-09-28 annual 2027-06-30 A$-0.08 A$-0.06 ▲ 0.02 A$1,731,791 A$1,731,791
2026-09-28 annual 2028-06-30 A$-0.06 A$-0.06 — A$17,456,453 A$17,456,453
2026-09-28 annual 2029-06-30 A$1.75 A$1.72 ▼ 0.03 A$994,409,037 A$981,288,857
2026-09-23 annual 2028-06-30 A$-0.06 A$-0.06 — A$17,456,453 A$17,456,453
2026-09-23 annual 2029-06-30 A$1.75 A$1.75 — A$994,423,010 A$994,409,037
2026-09-23 annual 2027-06-30 A$-0.08 A$-0.08 — A$1,731,791 A$1,731,791
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms